Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristine Broglio

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Cancer|November 17, 2006
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution studyAnne Uyei, Susan K Peterson, Julie Erlichman, et al.
The Lancet. Oncology|June 11, 2016
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trialDavid Cella, Viktor Grünwald, Paul Nathan, et al.
Clinical Breast Cancer|February 6, 2010
Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinomaEric J Silberfein, Kelly K Hunt, Kristine Broglio, et al.
Cancer|January 7, 2010
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancerStacy L Moulder, Frankie A Holmes, Anthony W Tolcher, et al.
Cancer|October 20, 2011
Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancerYun Wu, Elizabeth A Mittendorf, Canan Kelten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factorsValentina Guarneri, Kristine Broglio, Shu-Wan Kau, et al.
Cancer|August 9, 2011
Effect of CYP2D6 polymorphisms on breast cancer recurrencePhuong K Morrow, Ruben Serna, Kristine Broglio, et al.
Cancer|April 27, 2005
Women age < or = 35 years with primary breast carcinoma: disease features at presentationAna M Gonzalez-Angulo, Kristine Broglio, Shu-Wan Kau, et al.
Therapeutic Innovation & Regulatory Science|August 19, 2025
Company Sponsored Platform Trials: Recommendations and Lessons Learned from Cross-Industry InterviewsYujun Wu, Chengxing Cindy Lu, Mehreteab Aregay, et al.
Cancer|February 27, 2008
Prognostic significance of HER-2 status in women with inflammatory breast cancerShaheenah Dawood, Kristine Broglio, Yun Gong, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Cancer|November 17, 2006
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution studyAnne Uyei, Susan K Peterson, Julie Erlichman, et al.
The Lancet. Oncology|June 11, 2016
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trialDavid Cella, Viktor Grünwald, Paul Nathan, et al.
Clinical Breast Cancer|February 6, 2010
Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinomaEric J Silberfein, Kelly K Hunt, Kristine Broglio, et al.
Cancer|January 7, 2010
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancerStacy L Moulder, Frankie A Holmes, Anthony W Tolcher, et al.
Cancer|October 20, 2011
Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancerYun Wu, Elizabeth A Mittendorf, Canan Kelten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factorsValentina Guarneri, Kristine Broglio, Shu-Wan Kau, et al.
Cancer|August 9, 2011
Effect of CYP2D6 polymorphisms on breast cancer recurrencePhuong K Morrow, Ruben Serna, Kristine Broglio, et al.
Cancer|April 27, 2005
Women age < or = 35 years with primary breast carcinoma: disease features at presentationAna M Gonzalez-Angulo, Kristine Broglio, Shu-Wan Kau, et al.
Therapeutic Innovation & Regulatory Science|August 19, 2025
Company Sponsored Platform Trials: Recommendations and Lessons Learned from Cross-Industry InterviewsYujun Wu, Chengxing Cindy Lu, Mehreteab Aregay, et al.
Cancer|February 27, 2008
Prognostic significance of HER-2 status in women with inflammatory breast cancerShaheenah Dawood, Kristine Broglio, Yun Gong, et al.
Pageof 10